SCR 81 is a California Senate Concurrent Resolution that designates September 2025 as Chiari Malformation Awareness Month. The text collects legislative findings describing Chiari malformation (its types, typical symptoms, associated conditions, and an estimated U.S. prevalence) and cites ongoing research at the National Institute of Neurological Disorders and Stroke.
The measure is purely declaratory: it contains no appropriations, regulatory changes, or new programs. Its practical effect is symbolic recognition intended to increase public awareness, lend legislative imprimatur to outreach efforts, and support advocacy and research visibility across California.
At a Glance
What It Does
The resolution enumerates facts about Chiari malformation and formally proclaims September 2025 as Chiari Malformation Awareness Month. It directs the Secretary of the Senate to send copies of the resolution to the author for distribution.
Who It Affects
Patients with Chiari malformation and their families, disease advocacy groups, clinicians who diagnose/treat the condition, neuroscience researchers, and state or local public health communicators are the primary audiences for the proclamation.
Why It Matters
A state-level proclamation can amplify advocacy campaigns, encourage healthcare providers to promote screening and education, and increase visibility for research efforts — all without changing legal obligations or creating state-funded programs.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
SCR 81 compiles a set of legislative findings about Chiari malformation — a congenital condition involving downward displacement of cerebellar tissue — and uses those findings to justify a formal month-long awareness designation. The text describes common symptoms, associated diagnoses (for example, syringomyelia and hydrocephalus), and references the National Institutes of Health’s research efforts; those paragraphs are explanatory and do not create new clinical standards or reporting duties.
Because the measure is a concurrent resolution, it does not amend the California Codes, allocate funds, or require state agencies to take particular actions. The operative language is limited to the proclamation itself and an administrative instruction asking the Secretary of the Senate to transmit the resolution to the author so they can distribute copies.
The bill’s cover information records it as Chapter 136 and notes no fiscal committee referral was necessary.For practitioners and advocacy organizations, the resolution functions as a lever for awareness campaigns: it provides a clear, state-endorsed message that can be cited in outreach materials, fundraising appeals, clinician education, and event planning. For state or local public health officials it creates an opportunity to align communications in September, but it does not obligate them to allocate staff time or budgets.Finally, while the resolution raises the profile of Chiari malformation in California, it leaves unanswered whether follow-on legislative or budgetary actions will occur.
Any sustained programs, research grants, or service expansions would require separate statutory or budgetary measures.
The Five Things You Need to Know
SCR 81 is a Senate Concurrent Resolution (Chapter 136) filed July 10, 2025, not a bill that changes statute.
The text explicitly estimates more than 300,000 people in the U.S. are affected and lists common symptoms and related conditions (e.g.
syringomyelia, hydrocephalus).
The resolution cites ongoing research at the National Institute of Neurological Disorders and Stroke but does not direct state participation or funding for that research.
The operative directive is a single proclamation declaring September 2025 as Chiari Malformation Awareness Month and an administrative instruction to transmit copies to the author for distribution.
The bill includes a fiscal notation: no fiscal committee referral or appropriation is attached, signaling no intended state expenditure.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Findings and medical context
The preamble collects medical background: historical attribution to Hans Chiari, classification into four types, a prevalence estimate, typical symptoms, and common comorbid diagnoses. Practically, these clauses frame the rationale for recognition but do not impose duties; they are useful to advocates because the Legislature has consolidated clinical talking points into the official record.
Formal proclamation of September 2025
This is the operative clause that names September 2025 as Chiari Malformation Awareness Month. It is a declarative act: it signals legislative support but creates no regulatory or funding mandate. Organizations may cite this clause when planning events or awareness campaigns, but state entities are not legally required to act.
Administrative distribution to the author
The resolution directs the Secretary of the Senate to transmit copies to the author for appropriate distribution. That modest administrative step transfers responsibility for dissemination to the author’s office and interested parties rather than to a state agency, which limits state resource commitments.
Chaptering, filing date, and fiscal impact note
The document is recorded as Chapter 136 and notes it was filed with the Secretary of State on July 10, 2025. The Legislative Digest and fiscal fields indicate no fiscal committee action was necessary. Those formalities confirm the measure’s ceremonial nature and help stakeholders know it did not trigger budgetary review.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Patients with Chiari malformation and their families — the proclamation raises public awareness, can reduce diagnostic delay by encouraging clinicians and patients to consider Chiari in differential diagnoses, and strengthens advocacy narratives.
- Disease advocacy and patient organizations — the resolution provides a state-level endorsement they can cite in outreach, fundraising, and awareness-event promotion, increasing visibility and legitimacy for their campaigns.
- Clinicians and specialty centers (neurology, neurosurgery) — awareness month may increase referrals and opportunities for community education, CME events, and multidisciplinary coordination.
- Researchers and academic centers — legislative recognition can amplify visibility for research priorities and support recruitment for clinical studies by signaling public interest and concern.
Who Bears the Cost
- Secretary of the Senate and legislative staff — minimal administrative time to transmit and file copies and maintain the legislative record.
- State and local public health communicators (optional) — if health departments choose to participate, they may need to reallocate staff time for communications or events without new funding.
- Patient advocacy groups and nonprofits — they will likely absorb most operational costs for awareness events, materials, and outreach that rely on the proclamation rather than state grants.
Key Issues
The Core Tension
The central tension is symbolic recognition versus material action: the Legislature can raise awareness with minimal cost and broad visibility, but that same low-cost approach cannot deliver the funding, standardized clinical pathways, or sustained services that many affected patients and clinicians say are needed. Choosing a symbolic proclamation preserves fiscal and administrative flexibility while potentially leaving unmet expectations for concrete help.
The principal trade-off in SCR 81 is between symbolic recognition and concrete resource commitments. A month-long proclamation can help advocacy and education, but it does not allocate money, mandate screening protocols, or change clinical practice standards.
That limits how much practical benefit patients will see unless additional statutory or budgetary steps follow.
Implementation questions are minor but real. Who will coordinate state-level messaging if multiple organizations respond?
Will local health departments voluntarily align communications? There is also a risk of raising expectations: patients and families may interpret the proclamation as a promise of follow-up services or funding.
Finally, because the resolution places dissemination responsibility on the author’s office, the reach of the message will depend on private and non-governmental actors to convert symbolic recognition into programs or events.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.